Title |
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
|
---|---|
Published in |
PharmacoEconomics, December 2012
|
DOI | 10.2165/11598470-000000000-00000 |
Pubmed ID | |
Authors |
Lanting Lu, Hilary Pearce, Chris Roome, James Shearer, Iain A. Lang, Ken Stein |
Abstract |
Spasticity is common in patients with multiple sclerosis (MS) and is a major contributor to disability. Sativex®, an oromucosal spray containing cannabis-based medicinal products, has been found to be effective in reducing spasticity symptoms. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Unknown | 115 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 18 | 15% |
Student > Ph. D. Student | 13 | 11% |
Researcher | 13 | 11% |
Student > Master | 13 | 11% |
Student > Postgraduate | 9 | 8% |
Other | 23 | 20% |
Unknown | 28 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 24% |
Economics, Econometrics and Finance | 11 | 9% |
Agricultural and Biological Sciences | 9 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 8% |
Nursing and Health Professions | 6 | 5% |
Other | 20 | 17% |
Unknown | 34 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2021.
All research outputs
#2,170,361
of 25,371,288 outputs
Outputs from PharmacoEconomics
#149
of 1,991 outputs
Outputs of similar age
#20,122
of 289,080 outputs
Outputs of similar age from PharmacoEconomics
#6
of 280 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,080 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.